My research focuses on developing new statistical methods for identifying susceptibility loci involved in complex human disease. It involves a mix of genetics, statistics, and computer science and is motivated by the complexities of real data encountered in collaborative disease-gene mapping projects.
Andrew Allen received his Ph.D. from Emory University in 2001. Dr. Allen is also a member in the Duke Clinical Research Institute.